mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
8e-07 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
9e-07 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-06 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
1e-06 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-06 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
2e-06 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-06 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-06 |